Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2007
01/11/2007US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
01/11/2007US20070010531 Substituted pyrazole compounds
01/11/2007US20070010526 Therapeutic isoquinoline compounds
01/11/2007US20070010509 Cycloamine ccr5 receptor antagonists
01/11/2007US20070010457 Caspase inhibitors and uses thereof
01/11/2007US20070010452 Methionine aminopeptidase-2 inhibitors and methods of use thereof
01/11/2007US20070009980 Continuous fluorogenic analyte assays with dendritic amplification of signal
01/11/2007CA2614116A1 Histamine h3 receptor antagonists
01/11/2007CA2613435A1 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation
01/11/2007CA2613045A1 Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation
01/10/2007EP1741715A1 Epothilone derivatives and their synthesis and use
01/10/2007EP1741710A1 Pyrrolidine derivative
01/10/2007EP1741703A1 Pyridone derivative
01/10/2007EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
01/10/2007EP1741428A2 Cell adhesion inhibitors
01/10/2007EP1740580A2 Crystalline 2-amino-3-cyanoquinoline derivatives , process of their preparation and pharmaceutical compositions containing them
01/10/2007EP1740578A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
01/10/2007EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
01/10/2007EP1740574A2 4-amino-5-cyanopyrimidine derivatives
01/10/2007EP1740572A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
01/10/2007EP1740565A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sufide derivatives
01/10/2007EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
01/10/2007EP1740549A2 Novel imidazoles
01/10/2007EP1740548A1 Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of t cells and/or keratinocytes
01/10/2007EP1740185A1 Benzodiazepines for treating or preventing rsv infection
01/10/2007EP1740100A1 Xanthene dyes
01/10/2007EP1087946B1 Aryl alkanoylpyridazines
01/10/2007CN1894236A Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
01/10/2007CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels
01/10/2007CN1893949A Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
01/10/2007CN1891699A Therapeutic morpholino-substituted compounds
01/10/2007CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof
01/09/2007US7161012 Processes for preparing amorphous atorvastatin hemi-calcium
01/09/2007US7160999 The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl) -1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner
01/09/2007US7160955 Polymers with oxygen stability, heat resistance, radiation resistance and ozone resistance for polymers such as polybutadiene modified with sulfur or sulfoxide groups
01/09/2007US7160916 Method of increasing bone density or treating osteoporosis
01/09/2007US7160915 N-methyl-substituted benzamidazoles
01/09/2007US7160914 Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer
01/09/2007US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors
01/09/2007US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors
01/09/2007US7160891 Therapeutic treatment of autoimmune disease, transplant rejection, rheumatoid arthritis, by administering 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
01/09/2007US7160887 Aromatic amine derivatives, their production and use
01/09/2007US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
01/09/2007US7160877 Aliphatic nitrogen-containing 5-membered ring compound
01/09/2007US7160870 Thrombopoietin mimetics
01/09/2007US7160535 Cardiovascular disorders; antiischemic agents; complex of antioxidant and organometallic compound
01/09/2007CA2375372C Mutual prodrugs of amlodipine and atorvastatin
01/09/2007CA2294033C Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
01/09/2007CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
01/04/2007WO2007002584A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
01/04/2007WO2007002057A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
01/04/2007WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists
01/04/2007WO2007001249A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases
01/04/2007WO2007000334A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
01/04/2007WO2007000240A1 Isoquinoline derivatives as inhibitors of rho-kinase
01/04/2007WO2006100481A3 Preparations of 11c methyl iodide and of the radioligand 11c gb67
01/04/2007WO2006047479A3 C-fms kinase inhibitors
01/04/2007WO2006041872A3 Thrombin receptor antagonists
01/04/2007WO2005123050A3 Five-membered heterocycles useful as serine protease inhibitors
01/04/2007WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
01/04/2007US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems
01/04/2007US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents
01/04/2007US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
01/04/2007US20070004758 [2-Alkyl-3-(phenylaminocarbonyl)-4-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-5-(p-fluorophenyl)pyrrol-1-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; P38 map kinase inhibitors
01/04/2007US20070004729 Methods and compositions of novel triazine compounds
01/04/2007US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin
01/04/2007CA2611971A1 Nitrogen heterocycle biaryls for osteoporosis and other diseases
01/04/2007CA2611295A1 Isoquinoline derivatives as inhibitors of rho-kinase
01/04/2007CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists
01/04/2007CA2609957A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
01/03/2007EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
01/03/2007EP1737925A1 New organic luminescent element
01/03/2007EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
01/03/2007EP1737852A2 Polycyclic pyridines as potassium ion channel modulators
01/03/2007EP1737844A2 Bicyclic anthranilamide derivatives useful as insecticides
01/03/2007EP1737841A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
01/03/2007EP1737840A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
01/03/2007EP1737839A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds
01/03/2007EP1737838A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
01/03/2007EP1737830A1 Tri-substituted ureas as cytokine inhibitors
01/03/2007EP1737822A1 N-'4-4(4-morpholinyl) phenyl!-'(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors
01/03/2007EP1737463A1 Pyrimidines with tie2 (tek) activity
01/03/2007EP1737462A1 Pyrimidines with tie2 (tek) activity
01/03/2007EP1737414A2 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
01/03/2007EP1572685B1 Substituted benzodioxepins
01/03/2007EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
01/03/2007EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them
01/03/2007EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
01/03/2007CN1890235A Benzopyranone compounds, compositions thereof, and methods of treatment therewith
01/03/2007CN1890234A Novel quinoline derivatives
01/03/2007CN1890217A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B
01/03/2007CN1890208A Opioid receptor antagonists
01/03/2007CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases
01/03/2007CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase
01/03/2007CN1293076C Activator for peroxisome proliferator-activated receptor delta
01/03/2007CN1293075C Indole and 2,3-indoline derivative, their preparation and application
01/03/2007CN1293074C Arylindenopyridines with PDE inhibiting activity
01/03/2007CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
01/03/2007CN1293061C Novel branched substituted amino derivatives of 3-amino-1-phemyl-1H-[1,2,4]triazo, methods for producing them and pharmaceutica compositions containing them
01/03/2007CN1293059C New Carboxglic acid derivative, its preparation and application